Gilead Hepatitis Drugs Brought In $4.55 Billion in First Quarter. Pollack, Andrew, Gilead Sciences Inc, Hepatitis, Harvoni (Drug), Company Reports, Prices (Fares, Fees and Rates), Drugs (Pharmaceuticals), Sovaldi (Drug)